Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targetsBenjamin A. Nacev, William D. Tap, Satshil Rana et al.|Nature Communications|2022Cited by 219
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single centerEvan Rosenbaum, Sandra P. D’Angelo, Cristina R. Antonescu et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 58
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targetsBenjamin A. Nacev, William D. Tap, Francisco Sánchez-Vega et al.|medRxiv|2021Cited by 14
Abstract PR012: Targeted sequencing of 2,138 bone and soft tissue sarcomas reveals commonly altered pathways, subtype-independent genetic clusters, and potential therapeutic targetsBenjamin A. Nacev, William Tap, Francisco Sánchez-Vega et al.|Clinical Cancer Research|2022Cited by 0